These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18242898)

  • 21. smartCrystal combination technology--scale up from lab to pilot scale and long term stability.
    Al Shaal L; Müller RH; Shegokar R
    Pharmazie; 2010 Dec; 65(12):877-84. PubMed ID: 21284256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Freeze-drying of oleanolic acid-loaded nanosuspensions].
    Zhao XL; Chen HB; Chen YJ; Yang XL
    Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1874-6. PubMed ID: 18051893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
    Heiati H; Tawashi R; Phillips NC
    J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preserving hesperetin nanosuspensions for dermal application.
    Al Shaal L; Müller RH; Keck CM
    Pharmazie; 2010 Feb; 65(2):86-92. PubMed ID: 20225649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stability.
    Morakul B; Suksiriworapong J; Leanpolchareanchai J; Junyaprasert VB
    Int J Pharm; 2013 Nov; 457(1):187-96. PubMed ID: 24076396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic solubility and dissolution velocity of rutin nanocrystals.
    Mauludin R; Müller RH; Keck CM
    Eur J Pharm Sci; 2009 Mar; 36(4-5):502-10. PubMed ID: 19130880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
    Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals.
    Martena V; Shegokar R; Di Martino P; Müller RH
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1199-205. PubMed ID: 23815299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling.
    Van Eerdenbrugh B; Froyen L; Martens JA; Blaton N; Augustijns P; Brewster M; Van den Mooter G
    Int J Pharm; 2007 Jun; 338(1-2):198-206. PubMed ID: 17363200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
    Du B; Li XT; Zhao Y; A YM; Zhang ZZ
    Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
    Rosenblatt KM; Bunjes H
    Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
    Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
    Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
    Hawe A; Friess W
    Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization.
    Chow SF; Wan KY; Cheng KK; Wong KW; Sun CC; Baum L; Chow AH
    Eur J Pharm Biopharm; 2015 Aug; 94():436-49. PubMed ID: 26143368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
    Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.